Avvigo Guidance System
Payments companies reported to CMS as associated with Avvigo Guidance System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Avvigo Guidance System, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Avvigo Guidance System
These are the largest totals companies reported as associated with Avvigo Guidance System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Damian Grovas Abad | San Juan, PR | Interventional Cardiology | $45,504.37 |
| Ioannis Chatzizisis | Coral Gables, FL | Cardiovascular Disease | $39,779.83 |
| Hayder Hashim | Washington, DC | Cardiovascular Disease | $36,208.24 |
| Darshan Doshi | Boston, MA | Interventional Cardiology | $31,627.73 |
| Kevin Croce | Chestnut Hill, MA | Cardiovascular Disease | $18,893.87 |
| David Young | Jackson, MS | Interventional Cardiology | $7,518.88 |
| Allen Jeremias | E Setauket, NY | Cardiovascular Disease | $7,288.17 |
| Rhian Davies | York, PA | Cardiovascular Disease | $7,042.54 |
| Daniel Stewart | Louisville, KY | Interventional Cardiology | $7,023.11 |
| Vince Vismara | Columbia, SC | Interventional Cardiology | $6,673.84 |
Prescribed Avvigo Guidance System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.